Proteins implicated in the increase of adhesivity induced by suberoylanilide hydroxamic acid in leukemic cells
Jazyk angličtina Země Nizozemsko Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
23022583
DOI
10.1016/j.jprot.2012.09.014
PII: S1874-3919(12)00658-6
Knihovny.cz E-zdroje
- MeSH
- acetylace účinky léků MeSH
- buněčná adheze účinky léků MeSH
- buňky K562 MeSH
- časové faktory MeSH
- fosforylace účinky léků MeSH
- HL-60 buňky MeSH
- kyseliny hydroxamové farmakologie MeSH
- leukemie farmakoterapie metabolismus patologie MeSH
- lidé MeSH
- nádorové proteiny metabolismus MeSH
- proteom metabolismus MeSH
- protinádorové látky farmakologie MeSH
- vorinostat MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- kyseliny hydroxamové MeSH
- nádorové proteiny MeSH
- proteom MeSH
- protinádorové látky MeSH
- vorinostat MeSH
We have previously shown that suberoylanilide hydroxamic acid (SAHA) treatment increases the adhesivity of leukemic cells to fibronectin at clinically relevant concentrations. Now, we present the results of the proteomic analysis of SAHA effects on leukemic cell lines using 2-DE and ProteomLab PF2D system. Histone acetylation at all studied acetylation sites reached the maximal level after 5 to 10 h of SAHA treatment. No difference in histone acetylation between subtoxic and toxic SAHA doses was observed. SAHA treatment induced cofilin phosphorylation at Ser3, an increase in vimentin and paxillin expression and a decrease in stathmin expression as confirmed by western-blotting and immunofluorescence microscopy. The interaction of cofilin with 14-3-3 epsilon was documented using both Duolink system and coimmunoprecipitation. However, this interaction was independent of cofilin Ser3 phosphorylation and the amount of 14-3-3-ε-bound cofilin did not rise following SAHA treatment. SAHA-induced increase in the cell adhesivity was associated with an increase in PAK phosphorylation in CML-T1 cells and was abrogated by simultaneous treatment with IPA-3, a PAK inhibitor. The effects of SAHA on JURL-MK1 cells were similar to those of other histone deacetylase inhibitors, tubastatin A and sodium butyrate. The proteome analysis also revealed several potential non-histone targets of histone deacetylases.
Citace poskytuje Crossref.org